Spermidine in health and disease
Madeo F, Eisenberg T, Pietrocola F, Kroemer G
Published in Science
Abstract
Comprehensive review of spermidine as an autophagy inducer with anti-aging properties. Discusses mechanisms including histone acetylation, cardiovascular protection, neuroprotection, and metabolic benefits.
Methodology
Narrative review in Science synthesising mechanistic, animal-model and epidemiological evidence on spermidine.
Key Findings
Spermidine induces autophagy via inhibition of EP300 and hypusination of eIF5A, extends lifespan in yeast, flies, worms and mice, protects cardiac and neuronal tissue in rodent models, and higher dietary spermidine intake is associated with lower cardiovascular and all-cause mortality in human cohorts.
Conclusions
Spermidine is one of the best-characterised caloric-restriction mimetics, with strong preclinical lifespan and cardioprotection data and supportive but observational human evidence; randomised human outcome trials are still lacking.
Limitations
Review of predominantly animal and epidemiological data; human evidence is observational and confounded by overall diet quality, and optimal supplemental dose in humans is undefined.
Supplements Studied
Spermidine is a promising caloric-restriction mimetic, but human interventional evidence remains limited.
Outcomes Measured
Spermidine induces autophagy and extends lifespan in multiple model organisms, with supporting epidemiological human data.
Study Details
Access Study
Disclosures
Funding
Austrian Science Fund, European Research Council and related academic grants
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.